Insiders · CTNM

Olivia C Ware

Director at Contineum Therapeutics, Inc. (CTNM)

Olivia C Ware has filed 20 insider reports with the SEC since March 2021, as director at Contineum Therapeutics, Inc. (CTNM), director at Arcellx, Inc. (ACLX) and director at Revance Therapeutics, Inc. (RVNC). Olivia C Ware made no open-market purchases or sales in the last 12 months. The latest filing, on June 26, 2026, reports grant or award at Contineum Therapeutics, Inc. (CTNM).

Filings
20
Companies
3
Bought on market
None
Sold on market
$1.16M

Companies where Olivia C Ware is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Contineum Therapeutics, Inc. logo
CTNM
Contineum Therapeutics, Inc.
Director$9.04Jun 26, 2026
Arcellx, Inc. logo
ACLX
Arcellx, Inc.
Directorsince May 20220$1.16MApr 28, 2026
Revance Therapeutics, Inc. logo
RVNC
Revance Therapeutics, Inc.
Directorsince March 20210Feb 6, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Olivia C Ware with

Other insiders at the same companies

Questions about Olivia C Ware

What is Olivia C Ware's role at Contineum Therapeutics, Inc.?
Olivia C Ware reports to the SEC as director at Contineum Therapeutics, Inc. (CTNM), according to the latest filing on June 26, 2026. Olivia C Ware has also filed as director at Arcellx, Inc. (ACLX) and director at Revance Therapeutics, Inc. (RVNC).
Has Olivia C Ware bought or sold stock recently?
The most recent open-market sale was on April 16, 2024: sold 9,402 shares of Arcellx, Inc. (ACLX) for $522K at an average of $55.55.
How do I get alerts when Olivia C Ware files?
Follow Olivia C Ware on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Olivia C Ware (SEC CIK 0001663771). Totals count each trade once, skipping amendments whose original is on file, from Mar 10, 2021 on. View on SEC EDGAR · Get this as JSON